• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于联合方法筛选的生物标志物数据的肝癌预后预测模型的改进。

Improved prognostic prediction model for liver cancer based on biomarker data screened by combined methods.

机构信息

Faculty of Mathematical and Physical Sciences, University College London, London, WC1E 6BT, UK.

School of Clinical Medicine, Tsinghua University, Beijing 100084, China.

出版信息

Math Biosci Eng. 2023 Jan 11;20(3):5316-5332. doi: 10.3934/mbe.2023246.

DOI:10.3934/mbe.2023246
PMID:36896547
Abstract

Liver cancer is a common cause of death from cancer in the population, with the 4th highest mortality rate from cancer worldwide. The high recurrence rate of hepatocellular carcinoma after surgery is an important cause of high mortality among patients. In this paper, based on eight scheduled core markers of liver cancer, an improved feature screening algorithm was proposed based on the analysis of the basic principles of the random forest algorithm, and the system was finally applied to liver cancer prognosis prediction to improve the prediction of biomarkers for liver cancer recurrence, and the impact of different algorithmic strategies on the prediction accuracy was compared and analyzed. The results showed that the improved feature screening algorithm was able to reduce the feature set by about 50% while ensuring that the prediction accuracy was reduced within 2%.

摘要

肝癌是全球癌症死亡率第 4 高的癌症,也是人群中癌症死亡的常见原因。肝癌手术后的高复发率是导致患者死亡率高的重要原因。本文基于肝癌的 8 个预定核心标志物,在分析随机森林算法基本原理的基础上,提出了一种改进的特征筛选算法,并最终将该系统应用于肝癌预后预测,以提高肝癌复发的生物标志物预测,比较和分析了不同算法策略对预测准确性的影响。结果表明,改进的特征筛选算法在保证预测精度降低不超过 2%的情况下,能够将特征集减少约 50%。

相似文献

1
Improved prognostic prediction model for liver cancer based on biomarker data screened by combined methods.基于联合方法筛选的生物标志物数据的肝癌预后预测模型的改进。
Math Biosci Eng. 2023 Jan 11;20(3):5316-5332. doi: 10.3934/mbe.2023246.
2
Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.同型半胱氨酸:甲胎蛋白阴性肝细胞癌肝移植的新型预后生物标志物。
Cancer Biomark. 2020;29(2):197-206. doi: 10.3233/CBM-201545.
3
Methylation site 112043544 as a potential biomarker for post-transplant hepatocellular carcinoma recurrence.甲基化位点 112043544 作为移植后肝细胞癌复发的潜在生物标志物。
Future Oncol. 2022 Jun;18(19):2401-2413. doi: 10.2217/fon-2021-1608. Epub 2022 May 3.
4
Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.组织因子途径抑制物2的甲基化作为肝切除术后肝细胞癌的预后生物标志物
J Gastroenterol Hepatol. 2016 Feb;31(2):484-92. doi: 10.1111/jgh.13154.
5
Serologic and molecular biomarkers for recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysis.肝移植后肝细胞癌复发的血清学和分子生物标志物:一项系统综述和荟萃分析。
Transplant Rev (Orlando). 2016 Jul;30(3):171-7. doi: 10.1016/j.trre.2016.03.001. Epub 2016 Apr 9.
6
Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.肝移植后肝细胞癌复发的预测:四种基于肝外植体的预后模型比较
Liver Int. 2017 May;37(5):717-726. doi: 10.1111/liv.13388. Epub 2017 Mar 24.
7
Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation.肝移植后肝细胞癌肝内和肝外复发的十一种预后评分的有效性
J Cancer Res Clin Oncol. 2017 Dec;143(12):2595-2605. doi: 10.1007/s00432-017-2507-2. Epub 2017 Aug 28.
8
Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.去γ-羧基凝血酶原作为小肝细胞癌患者的重要预后指标。
World J Gastroenterol. 2008 Mar 7;14(9):1370-7. doi: 10.3748/wjg.14.1370.
9
Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.肝硬化患者接受尸体供肝肝移植后肝细胞癌早期复发的预测:一项多中心研究
Ann Transplant. 2019 Aug 20;24:489-498. doi: 10.12659/AOT.917296.
10
Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects.用于预测肝细胞癌复发的预后生物标志物:现状与未来展望。
World J Gastroenterol. 2014 Mar 28;20(12):3112-24. doi: 10.3748/wjg.v20.i12.3112.

引用本文的文献

1
Single cell and bulk transcriptome analysis identified oxidative stress response-related features of Hepatocellular Carcinoma.单细胞和批量转录组分析确定了肝细胞癌的氧化应激反应相关特征。
Front Cell Dev Biol. 2023 Sep 28;11:1191074. doi: 10.3389/fcell.2023.1191074. eCollection 2023.